Royalty Pharma Announces $3.3 Billion Royalty Transaction with Cystic Fibrosis Foundation Therapeutics

New York, NY - November 19, 2014 – Royalty Pharma announced today its acquisition of royalties on Vertex Pharmaceuticals’ cystic fibrosis treatments owned by Cystic Fibrosis Foundation Therapeutics’ (“CFFT”), an affiliate of the Cystic Fibrosis Foundation, for a cash payment of $3.3 billion.

© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.